ANEBULO PHARMACEUTICALS INC (ANEB)

US0345691036 - Common Stock

2.2999  +0.09 (+4.07%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2023-12-31)		 2023
(2023-6-30)		 2022
(2022-6-30)		 2021
(2021-6-30)		 2020
(2020-6-30)
ASSETS
Current Assets
Cash
6.64M11.25M14.55M19.99M3.02M
Cash Equivalents
N/AN/AN/A19.99M3.02M
Receivables
N/AN/AN/A0.000.00
Other Current Assets
171.74K420.00K1.03M1.67MN/A
Total Current Assets
6.82M11.67M15.58M21.65M3.03M
 
Non-Current Assets
Other Non-Current Assets
684.52KN/AN/AN/AN/A
Total Non-Current Assets
684.51K0.000.000.000.00
 
TOTAL ASSETS
7.50M11.67M15.58M21.65M3.03M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.00200.00K
Accrued Expenses
694.88K530.00K130.00K130.00K20.00K
Accounts Payable
318.68K530.00K380.00K110.00KN/A
Total Current Liabilities
1.01M1.07M510.00K240.00K220.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Total Non-Current Liabilities
0.000.000.000.000.00
 
TOTAL LIABILITIES
1.01M1.07M510.00K240.00K220.00K
 
SHAREHOLDERS' EQUITY
Retained Earnings
-62.40M-57.20M-45.47M-38.64M-170.00K
Additional Paid In Capital
68.86M67.78M60.51M60.03M0.00
Common Shares
25.93K30.00K20.00K20.00K2.98M
Shares Outstanding
25.93M25.63M23.34M23.34M23.27M
Tangible Book Value per Share
0.250.410.650.92-0.01
Total Shareholders' Equity
6.49M10.60M15.07M21.41M2.80M
 
TOTAL LIABILITIES AND EQUITY
7.50M11.67M15.58M21.65M3.03M
 
Statistics
Current Ratio
6.7310.9130.5590.2113.77
Return On Assets (ROA)
-139.96%-100.51%-43.84%-177.64%-5.61%
Return On Equity (ROE)
-161.83%-110.66%-45.32%-179.64%-6.07%

All data in USD

Charts